In contrast, in the fourth patient, who suffered from bilateral breast cancer, the samples (p-5 and p-33) show a difference in CNV and the ERBB2 AS, reaffirming the diagnosis of two independent tumors. This evidence concerns the gene ERBB2 and breast carcinoma.